# A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.

> **NCT03998319** · PHASE3 · RECRUITING · sponsor: **University of Sydney** · enrollment: 445 (estimated)

## Conditions studied

- STEMI
- Elevated IMR (>32)

## Interventions

- **DRUG:** Tenecteplase (1/3 systemic weight based dose)
- **OTHER:** Sterile water for injection (WFI)

## Key facts

- **NCT ID:** NCT03998319
- **Lead sponsor:** University of Sydney
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-10-14
- **Primary completion:** 2024-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 445 (ESTIMATED)
- **Last updated:** 2024-09-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03998319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03998319, "A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03998319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*